Search research articles
Contact Us
Filters
Showing results (31-40 of 61) with videos related to
Page
of 7
Sort By:
Therapeutic Advances in Medical Oncology
|
June 1, 2022
Durable objective response to sorafenib and role of sequential treatment in unresectable hepatocellular carcinoma
Kuo-Wei Huang, Pei-Chang Lee, Yee Chao, et al.
Alimentary Pharmacology & Therapeutics
|
November 25, 2024
Hepatic Events During Immune Checkpoint Inhibitor Treatment Between Liver and Non-Liver Malignancies in Hepatitis B Endemic Areas
Yi-Ping Hung, Pei-Chang Lee, Yen-Hwa Chang, et al.
American Journal of Cancer Research
|
August 6, 2021
Predictors of long-term recurrence and survival after resection of HBV-related hepatocellular carcinoma: the role of HBsAg
I-Cheng Lee, Hao-Jan Lei, Gar-Yang Chau, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
July 19, 2019
A new ALBI-based model to predict survival after transarterial chemoembolization for BCLC stage B hepatocellular carcinoma
I-Cheng Lee, Ya-Wen Hung, Chien-An Liu, et al.
Clinical Nutrition (Edinburgh, Scotland)
|
May 27, 2011
Impact of body mass index and viral load on liver histology in hepatitis B e antigen-negative chronic hepatitis B
I-Cheng Lee, Yi-Hsiang Huang, Che-Chang Chan, et al.
Journal of Hepatocellular Carcinoma
|
November 26, 2024
Diabetes Mellitus Negatively Impacts Outcomes of HBV-Related Hepatocellular Carcinoma Following Thermal Ablation
Kuo-Cheng Wu, I-Cheng Lee, Chien-An Liu, et al.
Journal for Immunotherapy of Cancer
|
June 23, 2022
Gut microbiota and metabolites associate with outcomes of immune checkpoint inhibitor-treated unresectable hepatocellular carcinoma
Pei-Chang Lee, Chi-Jung Wu, Ya-Wen Hung, et al.
Alimentary Pharmacology & Therapeutics
|
August 8, 2024
Impact of HCV eradication on recurrence pattern and long-term outcomes in patients with HCV-related hepatocellular carcinoma undergoing radiofrequency ablation
Kuo-Cheng Wu, I-Cheng Lee, Chen-Ta Chi, et al.
American Journal of Cancer Research
|
December 7, 2021
Comparable benefits of HCV eradication by direct acting antivirals and interferon-based therapy in patients with hepatocellular carcinoma undergoing surgical resection
Kuo-Cheng Wu, I-Cheng Lee, Chen-Ta Chi, et al.
Hepatology (Baltimore, Md.)
|
June 30, 2025
Distinct gut microbiota but common metabolomic signatures between viral and MASLD HCC contribute to outcomes of combination immunotherapy
Pei-Chang Lee, Chi-Jung Wu, Ya-Wen Hung, et al.
Page
of 7
Search research articles
Search
Showing results (31-40 of 61) with videos related to
Sort By:
Page
of 7
Therapeutic Advances in Medical Oncology
|
June 1, 2022
Durable objective response to sorafenib and role of sequential treatment in unresectable hepatocellular carcinoma
Kuo-Wei Huang, Pei-Chang Lee, Yee Chao, et al.
Alimentary Pharmacology & Therapeutics
|
November 25, 2024
Hepatic Events During Immune Checkpoint Inhibitor Treatment Between Liver and Non-Liver Malignancies in Hepatitis B Endemic Areas
Yi-Ping Hung, Pei-Chang Lee, Yen-Hwa Chang, et al.
American Journal of Cancer Research
|
August 6, 2021
Predictors of long-term recurrence and survival after resection of HBV-related hepatocellular carcinoma: the role of HBsAg
I-Cheng Lee, Hao-Jan Lei, Gar-Yang Chau, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
July 19, 2019
A new ALBI-based model to predict survival after transarterial chemoembolization for BCLC stage B hepatocellular carcinoma
I-Cheng Lee, Ya-Wen Hung, Chien-An Liu, et al.
Clinical Nutrition (Edinburgh, Scotland)
|
May 27, 2011
Impact of body mass index and viral load on liver histology in hepatitis B e antigen-negative chronic hepatitis B
I-Cheng Lee, Yi-Hsiang Huang, Che-Chang Chan, et al.
Journal of Hepatocellular Carcinoma
|
November 26, 2024
Diabetes Mellitus Negatively Impacts Outcomes of HBV-Related Hepatocellular Carcinoma Following Thermal Ablation
Kuo-Cheng Wu, I-Cheng Lee, Chien-An Liu, et al.
Journal for Immunotherapy of Cancer
|
June 23, 2022
Gut microbiota and metabolites associate with outcomes of immune checkpoint inhibitor-treated unresectable hepatocellular carcinoma
Pei-Chang Lee, Chi-Jung Wu, Ya-Wen Hung, et al.
Alimentary Pharmacology & Therapeutics
|
August 8, 2024
Impact of HCV eradication on recurrence pattern and long-term outcomes in patients with HCV-related hepatocellular carcinoma undergoing radiofrequency ablation
Kuo-Cheng Wu, I-Cheng Lee, Chen-Ta Chi, et al.
American Journal of Cancer Research
|
December 7, 2021
Comparable benefits of HCV eradication by direct acting antivirals and interferon-based therapy in patients with hepatocellular carcinoma undergoing surgical resection
Kuo-Cheng Wu, I-Cheng Lee, Chen-Ta Chi, et al.
Hepatology (Baltimore, Md.)
|
June 30, 2025
Distinct gut microbiota but common metabolomic signatures between viral and MASLD HCC contribute to outcomes of combination immunotherapy
Pei-Chang Lee, Chi-Jung Wu, Ya-Wen Hung, et al.
Page
of 7